Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Williams

Showing results (51-60 of 609) with videos related to

Pageof 61
Sort By:
American Journal of Hematology|January 11, 2016
Response to correspondence: Flow cytometric quantification of neutrophil extracellular traps: Limitations of the methodological approach by Ciepiela et alDavid A Williams, Mathilde Gavillet
Current Opinion in Hematology|March 25, 2020
Current and future gene therapies for hemoglobinopathiesChristian Brendel, David A Williams
Journal of Pediatric Hematology/Oncology|December 7, 2002
RAC2 GTPase deficiency and myeloid cell dysfunction in human and mouseYi Gu, David A Williams
Science (New York, N.Y.)|October 18, 2003
Medicine. Gene therapy--new challenges aheadDavid A Williams, Christopher Baum
Blood|August 9, 2014
Unexpected help: mTOR meets lentiviral vectorsChristian Brendel, David A Williams
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2008
A "vector drain" in US gene therapy development?Michel Sadelain, David A Williams
Experimental Cell Research|July 16, 2013
Hematopoietic-specific Rho GTPases Rac2 and RhoH and human blood disordersAnja Troeger, David A Williams
Rheumatic Diseases Clinics of North America|August 4, 2009
Advances in the assessment of fibromyalgiaDavid A Williams, Stephen Schilling
Blood Advances|December 14, 2021
Investigational curative gene therapy approaches to sickle cell diseaseDavid A Williams, Erica Esrick
Pediatric Blood & Cancer|September 22, 2012
Enough is indeed enough: ACGME required changes in pediatric trainingDavid A Williams, Jennifer Mack
Pageof 61

Showing results (51-60 of 609) with videos related to

Sort By:
Pageof 61
American Journal of Hematology|January 11, 2016
Response to correspondence: Flow cytometric quantification of neutrophil extracellular traps: Limitations of the methodological approach by Ciepiela et alDavid A Williams, Mathilde Gavillet
Current Opinion in Hematology|March 25, 2020
Current and future gene therapies for hemoglobinopathiesChristian Brendel, David A Williams
Journal of Pediatric Hematology/Oncology|December 7, 2002
RAC2 GTPase deficiency and myeloid cell dysfunction in human and mouseYi Gu, David A Williams
Science (New York, N.Y.)|October 18, 2003
Medicine. Gene therapy--new challenges aheadDavid A Williams, Christopher Baum
Blood|August 9, 2014
Unexpected help: mTOR meets lentiviral vectorsChristian Brendel, David A Williams
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2008
A "vector drain" in US gene therapy development?Michel Sadelain, David A Williams
Experimental Cell Research|July 16, 2013
Hematopoietic-specific Rho GTPases Rac2 and RhoH and human blood disordersAnja Troeger, David A Williams
Rheumatic Diseases Clinics of North America|August 4, 2009
Advances in the assessment of fibromyalgiaDavid A Williams, Stephen Schilling
Blood Advances|December 14, 2021
Investigational curative gene therapy approaches to sickle cell diseaseDavid A Williams, Erica Esrick
Pediatric Blood & Cancer|September 22, 2012
Enough is indeed enough: ACGME required changes in pediatric trainingDavid A Williams, Jennifer Mack
Pageof 61